全球指数

PAX GLOBAL(327.HK):NDR TAKEAWAYS:CHINA OUTLOOK BETTER THAN FEARED; OVERSEAS GROWTH IN THE FAST LANE

招商证券(香港)有限公司2015-08-12
FY15E guidance intact: 10%/30% YoY sales growth in China/Overseas, with accelerated product rollouts and market coverage.
Catalysts ahead: M&A in 2H15, multilane order wins, and sharegains with new wireless POS launch in China.
Maintain BUY with TP HK$12.4, based on 20.5x ex-cash P/E.Stable China growth back on track in 2H15Mgmt reiterated China FY15E sales guidance of 10% YoY (vs 0% in1H15), driven by share win-back from Chinese peers with new lower-ASPwireless POS product (launched in July) and stronger demand in 2H15on seasonality. Looking ahead, PAX expects healthy sales growth of 10-15% YoY in China, given continued replacement demand fromfeatures/security standards upgrade in tier-1/2 merchants and increasingmPOS penetration in micro-merchants. We expect PAX’s China sales togrow 18% YoY in 2H15, followed by 12.7%/12.6% in FY16E/17E.
Stronger products/execution in US/Brazil/Italy bearing fruitsFollowing strong momentum in Brazil/Africa/Middle East last year, PAX isset to accelerate expansion in selective underpenetrated markets. Mgmtexpects major breakthroughs in US (mkt size: 2.2mn) with 100%+ YoYsales growth in FY15E, on the back of EMV migration, stronger salesteam, upgraded products (mulitlane) amid Verifone’s weakness. ForBrazil (mkt size: 2mn), mgmt expect EFT-POS to ramp up in light ofmPOS‘s success. For Italy (mkt size: 250K), PAX will capture No.2position (20% mkt share) following strategic acquisition of PAX Italia.
Reiterate BUY as growth story remains intactPAX’s stock experienced a sharp correction in past two days due tomarket concern about potentially muted China growth after flattish salesin 1H15. We expect share price to rebound soon on its 2H15 outlook andpositive progress in overseas market. We maintain BUY with TPHK$12.4, based on 20.5x FY15E ex-cash P/E. PAX now trades at 13.3xex-cash FY15E P/E, 40%/78% discount to global peers/ A-share. Keyrisks include weaker China sales, product launch delays and M&A failure.

免责声明

以上内容仅供您参考和学习使用,任何投资建议均不作为您的投资依据;您需自主做出决策,自行承担风险和损失。九方智投提醒您,市场有风险,投资需谨慎。

推荐阅读

暂无数据

公司动态

    暂无数据

盘面综述

    暂无数据

IPO动态

    暂无数据

港股涨幅榜
  • 港股通
  • 红筹股
  • 国企股
  • 科技股
  • 名称/代码
  • 最新价
  • 涨跌幅

暂无数据

扫码关注

九方智投公众号

扫码关注

九方智投公众号